Assignee
AURIGENE DISCOVERY TECH LTD
IN·32 granted patents·22 pending applications·221 citations·filing 2012–2022
Top patents by PatentIndex Score
54 records- 0198US11680051B2Crystalline forms of 3-substituted 1,2,4-oxadiazoleAURIGENE DISCOVERY TECH LTD·Filed 2021·Granted Jun 20, 2023·6 cites·31 claims
- 0298US11465976B21,2,4-oxadiazole and thiadiazole compounds as immunomodulatorsAURIGENE DISCOVERY TECH LTD·Filed 2020·Granted Oct 11, 2022·10 cites·30 claims
- 0397US11136300B2Crystalline forms of 3-substituted 1,2,4-oxadiazoleAURIGENE DISCOVERY TECH LTD·Filed 2018·Granted Oct 5, 2021·13 cites·25 claims
- 0497US10995100B2Bicyclic heterocyclyl derivatives as IRAK4 inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2020·Granted May 4, 2021·6 cites·3 claims
- 0596US10781189B21,2,4-Oxadiazole and thiadiazole compounds as immunomodulatorsAURIGENE DISCOVERY TECH LTD·Filed 2016·Granted Sep 22, 2020·15 cites·38 claims
- 0696US9732095B2Bicyclic heterocyclyl derivatives as IRAK4 inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2015·Granted Aug 15, 2017·23 cites·135 claims
- 0795US11691987B2Bicyclic heterocyclyl derivatives as IRAK4 inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2021·Granted Jul 4, 2023·3 cites·22 claims
- 0895US9044442B2Peptidomimetic compounds as immunomodulatorsAURIGENE DISCOVERY TECH LTD·Filed 2013·Granted Jun 2, 2015·29 cites·17 claims
- 0994US11865114B2Method for treating diseases using SMARCA2/4 degradersAURIGENE DISCOVERY TECH LTD·Filed 2020·Granted Jan 9, 2024·5 cites·46 claims
- 1093US10047104B2Bicyclic heterocyclyl derivatives as IRAK4 inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2017·Granted Aug 14, 2018·11 cites·135 claims
- 1193US9937155B2Methods of use for trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2017·Granted Apr 10, 2018·6 cites·40 claims
- 1292US11174232B2Substituted heterocyclyl derivatives as CDK inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2020·Granted Nov 16, 2021·3 cites·14 claims
- 1391US11497734B2Dual inhibitors of TIM-3 and PD-1 pathwaysAURIGENE DISCOVERY TECH LTD·Filed 2018·Granted Nov 15, 2022·11 cites·29 claims
- 1491US10160753B2Indazole compounds as IRAK4 inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2015·Granted Dec 25, 2018·14 cites·129 claims
- 1591US9630932B2Trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2014·Granted Apr 25, 2017·13 cites·40 claims
- 1690US11497735B2Conjoint therapies for immunomodulationAURIGENE DISCOVERY TECH LTD·Filed 2018·Granted Nov 15, 2022·8 cites·31 claims
- 1790US10640517B2Bicyclic heterocyclyl derivatives as IRAK4 inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2018·Granted May 5, 2020·6 cites·135 claims
- 1889US10080740B2Trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2017·Granted Sep 25, 2018·6 cites·12 claims
- 1988US10689347B2Substituted heterocyclyl derivatives as CDK inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2016·Granted Jun 23, 2020·4 cites·30 claims
- 2088US9062075B2Tetrahydropyridine derivatives as FabI inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2014·Granted Jun 23, 2015·8 cites·19 claims
- 2187US11147801B2Methods of use for trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2018·Granted Oct 19, 2021·4 cites·12 claims
- 2281US11274123B21,2,4-oxadiazole compounds as inhibitors of CD47 signallingAURIGENE DISCOVERY TECH LTD·Filed 2019·Granted Mar 15, 2022·1 cites·17 claims
- 2381US9062002B2Substituted pyridine derivatives as FabI inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2012·Granted Jun 23, 2015·8 cites·19 claims
- 2480US11419875B2Compounds and compositions for treating hematological disordersAURIGENE DISCOVERY TECH LTD·Filed 2018·Granted Aug 23, 2022·5 cites·51 claims
- 2578US2023110077A11,2,4-Oxadiazole and Thiadiazole Compounds as ImmunomodulatorsAURIGENE DISCOVERY TECH LTD·Filed 2022·Application pending·0 cites
- 2676US11311517B2Combination of small molecule CD-47 inhibitors with other anti-cancer agentsAURIGENE DISCOVERY TECH LTD·Filed 2019·Granted Apr 26, 2022·2 cites·11 claims
- 2776US2023062570A1Dual inhibitors of tim-3 and pd-1 pathwaysAURIGENE DISCOVERY TECH LTD·Filed 2022·Application pending·0 cites
- 2875US11186576B2Pyrazolo[1,5-A][1,3,5]triazine and pyrazolo[1,5-A]pyrimidine derivatives as CDK inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2016·Granted Nov 30, 2021·1 cites·22 claims
- 2969US11229636B2Substituted tetrahydroquinolinone compounds as ROR gamma modulatorsAURIGENE DISCOVERY TECH LTD·Filed 2019·Granted Jan 25, 2022·0 cites·41 claims
- 3066US2019105304A1Trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2018·Application pending·0 cites
- 3164US2022281871A1Pyrazolo[1,5-A][1,3,5]Triazine and Pyrazolo[1,5-A]Pyrimidine Derivatives as CDK InhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2021·Application pending·0 cites
- 3260US2022339161A1Compounds and compositions for treating hematological disordersAURIGENE DISCOVERY TECH LTD·Filed 2022·Application pending·0 cites
- 3359US12371426B2Pyridazine derivatives as SMARCA2/4 degradersAURIGENE DISCOVERY TECH LTD·Filed 2019·Granted Jul 29, 2025·0 cites·118 claims
- 3459US2021379024A1Method of modulating tigit and pd-1 signalling pathways using 1,2,4-oxadiazole compoundsAURIGENE DISCOVERY TECH LTD·Filed 2019·Application pending·0 cites
- 3558US2020061030A1Dual inhibitors of vista and pd-1 pathwaysAURIGENE DISCOVERY TECH LTD·Filed 2017·Application pending·0 cites
- 3658US2016194295A11,3,4-Oxadiazole and 1,3,4-Thiadiazole Derivatives as ImmunomodulatorsAURIGENE DISCOVERY TECH LTD·Filed 2014·Application pending·0 cites
- 3758US2022324878A1Imidazolidin-2-one compounds as prmt5 modulatorsAURIGENE DISCOVERY TECH LTD·Filed 2022·Application pending·0 cites
- 3856US2018200247A1Substituted Tetrahydroquinolinone Compounds as ROR Gamma ModulatorsAURIGENE DISCOVERY TECH LTD·Filed 2016·Application pending·0 cites
- 3954US2018369206A1Methods of Use for Trisubstituted Benzotriazole Derivatives as Dihydroorotate Oxygenase InhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2018·Application pending·0 cites
- 4052US10894786B2Substituted pyrazole derivatives as selective CDK12/13 inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2019·Granted Jan 19, 2021·0 cites·25 claims
- 4150US2023027075A1Sulfonamide compounds targeting cd73 and adenosine receptorsAURIGENE DISCOVERY TECH LTD·Filed 2020·Application pending·0 cites
- 4249US2023212142A9Substituted 5-Cyclopropyl-1H-pyrazole-3-yl-amine Derivatives as Selective CDK12/13 InhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2020·Application pending·0 cites
- 4346US2023119355A1Pharmaceutical compositions of a kinase inhibitorAURIGENE DISCOVERY TECH LTD·Filed 2021·Application pending·0 cites
- 4444US11365205B2Imidazolidin-2-one compounds as PRMT5 modulatorsAURIGENE DISCOVERY TECH LTD·Filed 2019·Granted Jun 21, 2022·0 cites·16 claims
- 4541US11542275B2Substituted imidazolidin-2-one derivatives as PRMT5 inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2019·Granted Jan 3, 2023·0 cites·19 claims
- 4639US2015183781A15-(1H-Pyrazol-4-yl)-1H-Pyrrolo[2,3-b]Pyridine Derivatives as Kinase InhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2013·Application pending·0 cites
- 4738US9353107B23-(pyrazolyl)-1H-pyrrolo[2,3-b]pyridine derivatives as kinase inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2013·Granted May 31, 2016·0 cites·17 claims
- 4837US2018044305A13-substituted 1,3,4-oxadiazole and thiadiazole compounds as immunomodulatorsAURIGENE DISCOVERY TECH LTD·Filed 2016·Application pending·0 cites
- 4937US2018044329A13-substituted-1,2,4-oxadiazole and thiadiazole compounds as immunomodulatorsAURIGENE DISCOVERY TECH LTD·Filed 2016·Application pending·0 cites
- 5037US2018208605A1Substituted Aza Compounds as IRAK-4 InhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2016·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when AURIGENE DISCOVERY TECH LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →